Active substance
Results for the substance fruquintinib
2 results
About this active substance
Fruquintinib is a medication used in the treatment of certain types of cancer, especially advanced colorectal cancer. It works by inhibiting the formation of new blood vessels that supply the tumor, thereby slowing the growth and spread of cancer cells. Fruquintinib is usually taken as tablets, as directed by the oncologist.
Treatment with fruquintinib is given in cycles, and the dosage is determined based on the patient's overall condition and response to therapy. It is important for patients to strictly follow the dosing schedule and not stop treatment without consulting their doctor.
Common side effects may include high blood pressure, fatigue, diarrhea, loss of appetite, or skin reactions. In rare cases, more serious complications such as bleeding or liver problems may occur. Any unusual symptoms should be reported to the doctor immediately.
Fruquintinib provides an important therapeutic option for patients with advanced colorectal cancer, helping to prolong survival and improve quality of life. Careful monitoring and constant communication with the medical team are essential throughout the treatment.
Treatment with fruquintinib is given in cycles, and the dosage is determined based on the patient's overall condition and response to therapy. It is important for patients to strictly follow the dosing schedule and not stop treatment without consulting their doctor.
Common side effects may include high blood pressure, fatigue, diarrhea, loss of appetite, or skin reactions. In rare cases, more serious complications such as bleeding or liver problems may occur. Any unusual symptoms should be reported to the doctor immediately.
Fruquintinib provides an important therapeutic option for patients with advanced colorectal cancer, helping to prolong survival and improve quality of life. Careful monitoring and constant communication with the medical team are essential throughout the treatment.